Brittany Monceaux, MD
Sleep Medicine · Shreveport, LANPI 1639565708
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.0% of the total across 209 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations.
Across 209 payments — averaging $20.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$638
- Jazz Pharmaceuticals Inc.$633
- Biogen$469
- AstraZeneca$361
- Inspire Medical Systems, Inc.$278
- EMD Serono, Inc.$212
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,05594%
- Education$2616%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 39 | $638 |
| Jazz Pharmaceuticals Inc. | 18 | $633 |
| Biogen | 30 | $469 |
| AstraZeneca | 24 | $361 |
| Inspire Medical Systems, Inc. | 4 | $278 |
| EMD Serono, Inc. | 12 | $212 |
| Amgen | 10 | $192 |
| Argenx US, Inc. | 7 | $170 |
| AbbVie | 11 | $165 |
| Mallinckrodt Hospital Products Inc. | 7 | $142 |
| Tanabe Pharma America, Inc. | 7 | $120 |
| Itamar Medical Inc | 1 | $117 |
| UCB, Inc. | 5 | $115 |
| Neurelis, Inc. | 2 | $87 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $76 |
| Novartis | 4 | $67 |
| Teva Pharmaceuticals USA, Inc. | 3 | $64 |
| Idorsia Pharmaceuticals US Inc | 3 | $54 |
| Merz Pharmaceuticals, LLC | 2 | $52 |
| Neurocrine Biosciences, Inc. | 3 | $45 |
| Lilly USA, LLC | 2 | $41 |
| Lundbeck LLC | 2 | $34 |
| SK Life Science, Inc. | 1 | $24 |
| Biohaven Pharmaceuticals, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| ZOLL Respicardia, Inc. | 1 | $20 |
| Immedica Pharma US, Inc. | 1 | $18 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Amylyx Pharmaceuticals, Inc. | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
| MDD US Operations, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$247
- Inspire$139
- WatchPATONE$117
How this compares
$4,316 in reported general payments places this provider in the 70th percentile of 20 sleep medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Modafinil | 12 | $815 |
| Eszopiclone | 14 | $221 |
| Gabapentin | 16 | $127 |
| Zolpidem Tartrate | 11 | $94 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Shreveport
- Sara MunjampalliShreveport$19K
- Oleg ChernyshevShreveport$15K
- Naomi GhildiyalShreveport$3K
- Syeda MunirShreveport$344
- Megan SmalleyShreveport$265
- Mary Beth McGannShreveport$234
- Catherine OwensShreveport$130
- Matthew AbrahamLafayette$23K
- Joseph BordelonOpelousas$8K
- Dwayne HenryBaton Rouge$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.